About Diality
Diality is a Healthcare company based in Irvine (United States) founded in 2013. Developer of portable hemodialysis device. Diality has raised $82.5 million across 5 funding rounds. The company has 40 employees. Its chief executive, as recorded, is Osman Khawar. Diality offers products and services including Moda-flx Hemodialysis System and AR Viewer. Its focus areas include Life Sciences, Nephrology, Medical Devices and Therapeutic Devices. Its legal entity is Diality, Inc. Its competitors include Outset Medical and NxStage; 1 of its 2 listed competitors has raised funding.
Company details
Diality was founded in 2013 in Irvine, United States, and operates in the medical device sector focused on hemodialysis solutions. A portable device is being developed to enable patients to receive dialysis prescriptions at home, in nursing homes, hospitals, or dialysis centers. The technology is currently undergoing clinical trials and has not yet been approved for human use.
- Headquarters Irvine, United States
- Employees 40
- SectorsHealthcare
- Phone•••• ••••
- Website diality.com
- Social LinkedIn X Facebook Instagram
- Legal Name Diality, Inc
- Total Equity Funding$82.5M (USD)
in 5 rounds
- Latest Funding Round$28M (USD), Series C
Aug 2023
- Employee Count40
Products & Services of Diality
Diality offers a comprehensive portfolio of products and services, including Moda-flx Hemodialysis System and AR Viewer.
System for personalized dialysis treatment of renal failure patients.
Augmented reality tool for viewing hemodialysis system in care settings.
Funding Insights of Diality
Diality has successfully raised a total of $82.5M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $28 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $82.5M
- Total Rounds 5
- Last Round Series C — $28M
- First Round $8M
(Dec 2018)
All 5 funding rounds of Diality with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2023 | $28M | Series C | – | – | – |
| Mar 2022 | $24M | Series B | – | – | – |
| Aug 2020 | $12.5M | Series B | – | – | – |
| Nov 2019 | $10M | Series A | – | – | – |
| Dec 2018 | $8M | Series A | – | – | – |
People of Diality
26 people are tracked at Diality (12 in leadership, 7 in board & advisors, 7 in team); the tracked headcount is 40.
| Name | Role | Group |
|---|---|---|
Osman Khawar | CEO | Leadership |
Jahnavi Lokre | COO | Leadership |
Clayton Poppe | CTO | Leadership |
Matthew Wilson | Vice President, Human Resources | Leadership |
Haiwen Yu | Associate Director, Hardware Engineering | Leadership |
Olga Alayev | Vice President Operations | Leadership |
Courtney Naismith | VP Of Finance And Accounting | Leadership |
Austin Sorich | Director Of Manufacturing | Leadership |
Sandeep Lad | Director, Quality | Leadership |
Sheila Holley | Director, Human Resources | Leadership |
Andy Veldkamp | Marketing Director | Leadership |
Denny Keo | Director Of Field Service | Leadership |
Shaun Collard | Advisor | Board & advisors |
Timothy McNamara | Vice President Medical Affairs | Board & advisors |
Robert Funari | Board Member | Board & advisors |
Martin Riediker | Board Member | Board & advisors |
Gary Limon | Advisor | Board & advisors |
Allen R. Nissenson | Board Member | Board & advisors |
Kamyar Kalantar-Zadeh | Advisor | Board & advisors |
Daniel Guthrie | CBO | Team |
6 more people are available in the full profile.
Complete people profiles for Diality
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Diality
3 dated milestones of Diality across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Diality is founded.
- Funding First funding round of $8.0M.
- Funding Latest funding round, Series C, of $28.0M.
Competitors of Diality
Diality has 2 listed competitors in our database, 1 of them funded. They include Outset Medical and NxStage.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| outsetmedical.com | 2003 | San Jose, United States | $457.87M | 372 | Hemodialysis machines with touchscreen displays are provided for medical use. | |
| nxstage.com | 1998 | Lawrence, United States | 732 | Home and critical care dialysis systems |
Detailed competitors of Diality
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Diality
The website of Diality (diality.com) receives about 2.1K visits a month.
- Monthly visits2.1K
▼ 21.3% vs previous month
Top companies in Nephrology
3 companies that operate in the same segment as Diality (Nephrology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Hemodialysis machines with touchscreen displays are provided for medical use. | 2003 | San Jose, California, United States | USD 457.87 M | USD 119.48 M | ||
Therapeutics for kidney disease treatment are developed by Akebia Therapeutics. | 2007 | Cincinnati, Ohio, United States | USD 91 M | USD 236.2 M | 181 | |
Small molecule therapies for kidney diseases are developed. | 2016 | San Francisco, California, United States | USD 1.55 M | 22 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Diality
Complete news archive for Diality
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Diality
Diality was founded in 2013 and raised its 1st funding round 5 years after it was founded.
Diality is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Osman Khawar is the CEO of Diality, as recorded in our data.
Diality is a funded company, having raised a total of $82.5M across 5 funding rounds to date. The company's 1st funding round was a Series A of $8M, raised on Dec 2018.
Diality has 40 employees.
Diality was founded in 2013 in Irvine, United States, and operates in the medical device sector focused on hemodialysis solutions. A portable device is being developed to enable patients to receive dialysis prescriptions at home, in nursing homes, hospitals, or dialysis centers. The technology is currently undergoing clinical trials and has not yet been approved for human use.
Diality's top competitors include Outset Medical and NxStage.
Diality offers Moda-flx Hemodialysis System and AR Viewer.
Diality operates through Diality, Inc.